Borate(1-), tris(acetato-.kappa.O)hydro-, sodium, (T-4)-

Endpoint summary

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2004-08-11 1 2004-09-08

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: OECD guideline study according GLP

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Remarks:

Swiss Federal Office of Public Health, 2003

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

CBA

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL-5960 AD Horst, The Netherlands
- Age at study initiation: 8- 12 weeks
- Weight at study initiation: 16 – 24 g
- Housing: Individually in Makrolon type-2 cages with standard softwood bedding (“Lgnocel”, Schill AG, CH-4132 Muttenz, Switzerland)
- Diet (e.g. ad libitum): Diet (e.g. ad libitum): Pelleted standard Provimi Kliba 3433 rat/mouse maintenance diet, batch No. 54/03 and 78/03 (Provimi Kliba AG, CH-4303 Kaiseraugst, Switzerland); ad libitum
- Water (e.g. ad libitum): Community tap water from Füllinsdorf; ad libitum
- Acclimation period: Under test conditions under health examinations.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30 - 70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12 / 12

Vehicle:

dimethylformamide

Concentration:

Pre-test: 2.5%, 5%, 10% and 25%
Main test: 0, 5%, 10% and 25%

No. of animals per dose:

Pre-test: 2 females
Main test: 4 females

Details on study design:

RANGE FINDING TESTS:
- Irritation: 24 h after single topical application of 2.5%, 5%, 10% and 25% to the ears of two females, no irritation was observed at all concentrations.
- Lymph node proliferation response:

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph node Assay (LLNA)
- Criteria used to consider a positive response:
The proliferation response of lymph node cells was expressed as the number of radioactive disintegration per minute per lymph node and as ratio of 3HTdR incorporated into lymph node cells of the test group relative to control group values.
The test item was regarded as sensitizer if the following criteria are fulfilled:
- Exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater the control values as indicated by the stimulation index SI
- The data are compatible with a dose response, although allowance must be made for local toxicity or immunological suppression

TREATMENT PREPARATION AND ADMINISTRATION:
Animals were treated by topical application of 25 µl solution of test substance in DMF to the dorsal surface of each ear lobe once a day for three consecutive days. Five days after the first application, all mice received application of 250 µl of 73.3 µCi/ml 3HTdR by intravenous injection. Five hours after this treatment all animals were sacrificed and lymph nodes were excised and prepared for determination of incorporated 3HTdR.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Parameter:

SI

Remarks on result:

other: 5%: 0.7 10%: 1.2 25%: 1.1

Parameter:

other: disintegrations per minute (DPM)

Remarks on result:

other: Mean over 8 lymph nodes): Vehicle control: 2357 5%: 1741 10%: 2784 25%: 2598

Viability: No mortality was noted.

Clinical signs: No symptoms of local toxicity at the ears and no signs of systemic was noted in all animals during the study.

Body weights: The body weights of all animals were within the range commonly recorded for the animals of the strain and age.

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

Sodium triacetoxyborohydride did not induce an increase incorporation in mouse lymph node cells and thus was found to be a non-sensitizer .

Executive summary:

Sodium triacetoxyborohydride was tested for sensitizing properties in a Local Lymph Node Assay (LLNA) performed according to GLP and OECD 429. Groups of 4 female CBA mice were treated by topical application of 25 µl solution of 5%, 10% and 25% Sodium triacetoxyborohydride in DMF to the ears once daily for three consecutive days. The resulting stimulating indices (SI) were 0.7, 1.2 and 1.1, respectively. Thus, Sodium triacetoxyborohydride was not sensitizing under the condition of this test.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

Sodium triacetoxyborohydride was tested for sensitizing properties in a Local Lymph Node Assay (LLNA) performed according to GLP and OECD 429. Groups of 4 female CBA mice were treated by topical application of 25 µl solution of 5%, 10% and 25% Sodium triacetoxyborohydride in DMF to the ears once daily for three consecutive days. The resulting stimulating indices (SI) were 0.7, 1.2 and 1.1, respectively. Thus, Sodium triacetoxyborohydride was not sensitizing under the condition of this test.

Migrated from Short description of key information:
Skin: Not sensitizing (OECD 429)

Justification for selection of skin sensitisation endpoint:
Reliable guideline study according GLP

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

The available data on sensitization of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.